People, aged from 18-59 and residing in Hanoi , are encouraged to register for human trials of Vietnam's second COVID-19 vaccine candidate COVIVAC (Photo: VNA) Hanoi (VNA) – People, aged from 18-59 and residing in Hanoi, can register for human t rials of Vietnam's second COVID-19 vaccine candidate COVIVAC from March 5 morning. In the first phase of the trials, 150 healthy volunteers will be injected with two doses of 0.5ml with an interval of 28 days. They will be divided into five groups, including one group provided with placebo shots, and their health will be closely monitored within 24 hours after injections. Each volunteer will have their health checked-up eight times in 12 months. After 43 days since the first phase starts and shows good results, the second phase will be carried out at the medical centre of Thai Binh province's Vu Thu district, with 300 volunteers. The homegrown vaccine has been developed by the Nha Trang-based Institute of Vaccines and Medical Biologicals (IVAC) and the Hanoi Medical University since last May, using primary chicken embryo cell culture, a technique the institute used previously to successfully produce seasonal flu vaccines. COVIVAC has undergone pre-clinical trials in India, the US, and Vietnam,… Read full this story
- Northland primary school raises nearly $20,000 for students' meningococcal vaccines
- Obanikoro testifies at Fayose’s trial
- Teen, 19, found guilty of killing Jaden Moodie, 14, in gangland murder
- Trapped in a hoax: survivors of conspiracy theories speak out
- Oh God I never knew a day like this will come Evans said, witness tells court
- Our books of the year
- NHS workers, charities and health heroes celebrated in The Sun’s Who Cares Wins awards 2019
- 70 defining moments in 70 years of the NHS
- Syria’s truth smugglers
- Vulvar Cancer: Types, Symptoms, Causes And Treatment
Volunteers sought for second homegrown COVID-19 vaccine trials have 284 words, post on en.vietnamplus.vn at March 5, 2021. This is cached page on VietMaz. If you want remove this page, please contact us.